Dana-Farber to Use InforSense Informatics Platform | GenomeWeb
NEW YORK (GenomeWeb News) – The Dana-Farber Cancer Institute will use InforSense’s ClinicalSense cohort selection and clinical decision support product in its oncology research and patient care, the partners announced today.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.